Sign In
Buy TARO
$42.97
+0 (+0%)
At Close: Sep 20, 2024
All You Need to Know About Taro (TARO) Rating Upgrade to Strong Buy
01:32pm, Wednesday, 01'st Nov 2023
Taro (TARO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Taro Pharmaceutical (TARO) Tops Q2 Earnings Estimates
07:33pm, Thursday, 26'th Oct 2023
Taro Pharmaceutical (TARO) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to loss of $0.07 per share a year ago.
These Israeli pharmaceutical stocks are down in the wake of Hamas attack
08:53am, Monday, 09'th Oct 2023
Shares of Israeli pharmaceutical companies took a hit in premarket trades Monday after Hamas' attack on Israel.
Taro to Release First Quarter Results on July 26, 2023
04:00pm, Wednesday, 19'th Jul 2023
HAWTHORNE, N.Y.--(BUSINESS WIRE)--TARO TO RELEASE FIRST QUARTER RESULTS ON JULY 26, 2023.
Krensavage Asset Management Opposes Sun's Lowball Bid for Taro
07:00am, Wednesday, 19'th Jul 2023
NEW YORK , July 19, 2023 /PRNewswire/ -- As the largest minority shareholder1 of Taro Pharmaceutical Industries Ltd. (NYSE: TARO), Krensavage Asset Management LLC opposes Sun Pharmaceutical Industries
Taro Pharmaceutical: Potential Value In Sun Pharma Offer
02:41pm, Friday, 02'nd Jun 2023
Taro received a $38/share offer from Sun Pharma last month. The deal represents a decent premium to the firm's market value at the time and a 12% premium to my estimate of fair value. Further insights
Why Shares of Taro Pharmaceutical Are Rising Tuesday
12:25pm, Tuesday, 30'th May 2023
Taro saw rising revenue in the fourth quarter but falling net income. Sun Pharmaceutical already owns 78.5% of Taro's shares.
Taro Provides Results for Year Ended March 31, 2023
07:00pm, Tuesday, 23'rd May 2023
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31,
Taro to Release Full Year Results on May 23, 2023
04:46pm, Thursday, 18'th May 2023
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the year ended March 31, 2023, after the close of
Taro Pharmaceutical: Stagnating Growth At 1.6% Trailing Earnings Yield, Rate Hold
12:18am, Friday, 24'th Feb 2023
Taro Pharmaceutical's quarterly numbers came in with very thin growth at the operating and bottom-lines given the impact from settlement charges. Price erosion in its U.S. generics business continues
Francisco Garcia Parames' Cobas Funds 4th-Quater Letter
06:01pm, Wednesday, 22'nd Feb 2023
Dear Investor:
Taro Pharmaceutical (TARO) Lags Q3 Earnings and Revenue Estimates
08:19pm, Tuesday, 24'th Jan 2023
Taro (TARO) delivered earnings and revenue surprises of -78.16% and 14.66%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Taro to Release Third Quarter Results on January 24, 2023
05:02pm, Thursday, 19'th Jan 2023
HAWTHORNE, N.Y.--( BUSINESS WIRE )--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the third quarter ended December 31, 2022, after
Taro Pharmaceutical (TARO) Reports Q2 Loss, Misses Revenue Estimates
09:04pm, Thursday, 27'th Oct 2022
Taro (TARO) delivered earnings and revenue surprises of -108.33% and 18.96%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Taro to Release Second Quarter Results on October 27, 2022
12:37pm, Monday, 24'th Oct 2022
HAWTHORNE, N.Y.
